Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate vs Phenytoin in New Onset Epilepsy
NCT00210782Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jun 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of topiramate in epilepsy, sponsored by Johnson & Johnson. Started Jun 2004; status: completed.
02
Drugs
topiramate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00210782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210782.